Atomo Diagnostics Limited (ASX:AT1)
Australia · Delayed Price · Currency is AUD 0.0180
+0.0010 (5.88%)
Sep 17, 2026, 3:55 PM AEST
Atomo Diagnostics Market Cap
Atomo Diagnostics has a market cap or net worth of 15.34 million as of September 17, 2026. Its market cap has decreased by -5.32% in one year.
Market Cap
15.34M
Enterprise Value
12.01M
Revenue
5.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
ChartMarket Cap Chart
Since April 16, 2020, Atomo Diagnostics's market cap has decreased from 218.82M to 15.34M, a decrease of -92.99%. That is a compound annual growth rate of -33.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 16.24M | -44.31% |
| Dec 31, 2025 | 29.17M | 140.15% |
| Dec 31, 2024 | 12.14M | -13.64% |
| Dec 29, 2023 | 14.06M | -54.38% |
| Dec 30, 2022 | 30.83M | -81.93% |
| Dec 31, 2021 | 170.58M | -1.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cleo Diagnostics | 42.50M |
| HeraMED | 38.24M |
| Nova Eye Medical | 37.03M |
| OncoSil Medical | 35.41M |
| Control Bionics | 33.13M |
| CleanSpace Holdings | 30.16M |
| Memphasys | 18.52M |
| ImpediMed | 18.31M |